324.34
前日終値:
$325.80
開ける:
$324.77
24時間の取引高:
328.72K
Relative Volume:
0.54
時価総額:
$22.83B
収益:
$2.36B
当期純損益:
$236.10M
株価収益率:
98.70
EPS:
3.286
ネットキャッシュフロー:
$382.50M
1週間 パフォーマンス:
-1.41%
1か月 パフォーマンス:
+1.99%
6か月 パフォーマンス:
+24.98%
1年 パフォーマンス:
+38.98%
Insulet Corporation Stock (PODD) Company Profile
PODD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
PODD
Insulet Corporation
|
324.34 | 22.93B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
126.61 | 221.35B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
100.97 | 151.78B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
375.93 | 146.70B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
93.23 | 120.73B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.19 | 47.45B | 5.69B | 1.41B | 577.90M | 6.9828 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | 再開されました | Oppenheimer | Outperform |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-05-13 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-07 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-21 | アップグレード | Citigroup | Neutral → Buy |
| 2023-08-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-01 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-07-28 | 開始されました | Wells Fargo | Overweight |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 開始されました | BofA/Merrill | Neutral |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-12-10 | 開始されました | CFRA | Sell |
| 2019-10-23 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-10-04 | ダウングレード | UBS | Buy → Neutral |
| 2019-10-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-08-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-06-10 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-04-20 | 開始されました | Berenberg | Buy |
| 2018-02-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 開始されました | Barclays | Overweight |
すべてを表示
Insulet Corporation (PODD) 最新ニュース
How institutional ownership impacts Insulet Corporation stockPortfolio Performance Summary & Technical Confirmation Trade Alerts - newser.com
Multi asset correlation models including Insulet Corporation2025 Market Outlook & Weekly High Conviction Ideas - newser.com
Will Insulet Corporation rebound enough to break evenPortfolio Gains Summary & Target Return Focused Stock Picks - newser.com
Is Insulet Corporation stock a buy before product launchesCEO Change & Weekly Momentum Picks - newser.com
Why Insulet Corporation stock appeals to dividend seekersJuly 2025 Snapshot & Long-Term Safe Investment Ideas - Fundação Cultural do Pará
Why Insulet Corporation (GOV) stock stays resilientJobs Report & Weekly Momentum Stock Picks - newser.com
United States Insulin Pump Market Outlook and Company Analysis Report 2025-2033 Featuring Medtronic, Insulet, Tandem Diabetes Care, Roche, Ypsomed, Microtech Medical - Yahoo! Finance UK
Advanced analytics toolkit walkthrough for Insulet CorporationQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
Sector ETF performance correlation with Insulet CorporationGlobal Markets & Risk Adjusted Swing Trade Ideas - newser.com
Full technical analysis of Insulet Corporation stockOil Prices & Growth Focused Stock Reports - newser.com
Why Insulet Corporation (GOV) stock could outperform next yearWeekly Market Report & Reliable Price Breakout Alerts - newser.com
Will Insulet Corporation stock deliver strong dividend growth2025 Earnings Impact & Expert Approved Momentum Trade Ideas - newser.com
How to interpret RSI for Insulet Corporation stock2025 Year in Review & Low Drawdown Momentum Ideas - newser.com
Can Insulet Corporation stock sustain revenue growthTrade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
Why Insulet Corporation (GOV) stock could break out in 2025Profit Target & Accurate Intraday Trading Signals - newser.com
How to monitor Insulet Corporation with trend dashboardsJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Insulet’s New Study on Simplified Onboarding for Type 2 Diabetes Management: A Potential Game Changer - TipRanks
Will Insulet Corporation outperform the marketWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com
Insulet’s Omnipod 5 Study: A Real-World Evaluation of Diabetes Management - TipRanks
Insulet’s Omnipod 5 SA2.0 Study: A Leap in Diabetes Management - TipRanks
Why Insulet Corporation stock could outperform in 20252025 Bull vs Bear & Daily Volume Surge Signals - newser.com
Insulet Corporation (PODD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):